Medpace Holdings, Inc. (MEDP)Healthcare | Diagnostics & Research | Cincinnati, United States | NasdaqGS
609.89 USD
-10.16
(-1.639%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 609.89 |
Hot Take ↕ | Oct. 10, 2026, 9:36 a.m. EDT
Medpace represents a rare compounder with exceptional capital efficiency, boasting a 162% return on equity and sustained 17% revenue growth over the last decade. The balance sheet is fortified with net cash, and the nine-year price trajectory shows a 1,556% cumulative gain without a trailing multi-year decline, validating the business quality. However, the stock trades at a premium valuation with a forward P/E near 32x, and recent executive sales totaling millions of dollars create a headwind for immediate entry. While options flow shows aggressive bullish positioning for targets well above current levels, the heavy put volume near the current price suggests traders are wary of volatility. For a long-term portfolio, the fundamentals are unambiguously excellent, but the short-term path requires patience amidst insider distribution and high valuation. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.043027 |
| AutoETS | 0.043452 |
| AutoARIMA | 0.043452 |
| MSTL | 0.055655 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 17.35 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.399 |
| Excess Kurtosis | -0.98 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 33.216 |
| Revenue per Share | 98.469 |
| Market Cap | 17,023,040,512 |
| Trailing P/E | 35.81 |
| Forward P/E | 31.58 |
| Beta | 1.18 |
| Profit Margins | 17.66% |
| Website | https://www.medpace.com |
As of Oct. 10, 2026, 9:36 a.m. EDT: Speculators are positioning for upside continuation with heavy out-of-the-money call open interest at strikes above $700, suggesting bets on a move toward $800 by late 2027. Conversely, significant put open interest clusters near the current price ($570-$600) alongside elevated implied volatility on deep in-the-money strikes indicates a defensive stance, with traders hedging against a potential correction despite the bullish call flow.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.20557237 |
| Address1 | 5,375 Medpace Way |
| All Time High | 677.9 |
| All Time Low | 21.76 |
| Ask | 620.0 |
| Ask Size | 1 |
| Audit Risk | 6 |
| Average Analyst Rating | 2.9 - Hold |
| Average Daily Volume10 Day | 242,140 |
| Average Daily Volume3 Month | 270,514 |
| Average Volume | 270,514 |
| Average Volume10Days | 242,140 |
| Beta | 1.181 |
| Bid | 613.79 |
| Bid Size | 1 |
| Board Risk | 7 |
| Book Value | 15.545 |
| City | Cincinnati |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 609.89 |
| Current Ratio | 0.732 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 620.06 |
| Day Low | 609.48 |
| Debt To Equity | 33.216 |
| Display Name | Medpace |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,792,699,200 |
| Earnings Call Timestamp Start | 1,792,699,200 |
| Earnings Growth | 0.371 |
| Earnings Quarterly Growth | 0.345 |
| Earnings Timestamp | 1,792,612,800 |
| Earnings Timestamp End | 1,792,612,800 |
| Earnings Timestamp Start | 1,792,612,800 |
| Ebitda | 611,200,000 |
| Ebitda Margins | 0.21968001 |
| Enterprise To Ebitda | 27.265 |
| Enterprise To Revenue | 5.989 |
| Enterprise Value | 16,664,463,360 |
| Eps Current Year | 17.71533 |
| Eps Forward | 19.31534 |
| Eps Trailing Twelve Months | 17.03 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 513 579 0444 |
| Fifty Day Average | 603.3492 |
| Fifty Day Average Change | 6.5408325 |
| Fifty Day Average Change Percent | 0.010840874 |
| Fifty Two Week Change Percent | 20.557236 |
| Fifty Two Week High | 677.9 |
| Fifty Two Week High Change | -68.01001 |
| Fifty Two Week High Change Percent | -0.10032454 |
| Fifty Two Week Low | 373.0 |
| Fifty Two Week Low Change | 236.89001 |
| Fifty Two Week Low Change Percent | 0.63509387 |
| Fifty Two Week Range | 373.0 - 677.9 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,470,922,200,000 |
| Float Shares | 22,657,565 |
| Forward Eps | 19.31534 |
| Forward P E | 31.575422 |
| Free Cashflow | 510,396,512 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 6,500 |
| Fullday Change | -10.159973 |
| Fullday Change Percent | -1.6385733 |
| Fullday Price | 609.89 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.7235 |
| Gross Profits | 2,012,973,056 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.18756 |
| Held Percent Institutions | 0.90774 |
| Implied Shares Outstanding | 27,911,655 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. |
| Long Name | Medpace Holdings, Inc. |
| Market | us_market |
| Market Cap | 17,023,040,512 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_260345878 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 491,500,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 17,225,677,883 |
| Number Of Analyst Opinions | 13 |
| Open | 620.05 |
| Operating Cashflow | 752,659,968 |
| Operating Margins | 0.20757 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.95 |
| Phone | 513 579 9911 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 609.89 |
| Post Market Time | 1,791,921,619 |
| Previous Close | 620.05 |
| Price Eps Current Year | 34.427246 |
| Price Hint | 2 |
| Price To Book | 39.233837 |
| Price To Sales Trailing12 Months | 6.1183605 |
| Profit Margins | 0.17665 |
| Quick Ratio | 0.658 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.92857 |
| Region | US |
| Regular Market Change | -10.16 |
| Regular Market Change Percent | -1.63857 |
| Regular Market Day High | 620.06 |
| Regular Market Day Low | 609.48 |
| Regular Market Day Range | 609.48 - 620.06 |
| Regular Market Open | 620.05 |
| Regular Market Previous Close | 620.05 |
| Regular Market Price | 609.89 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 155,250 |
| Return On Assets | 0.20096001 |
| Return On Equity | 1.6215401 |
| Revenue Growth | 0.172 |
| Revenue Per Share | 98.469 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 27,911,655 |
| Shares Percent Shares Out | 0.0572 |
| Shares Short | 1,596,293 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,670,695 |
| Short Name | Medpace Holdings, Inc. |
| Short Percent Of Float | 0.0713 |
| Short Ratio | 6.58 |
| Source Interval | 15 |
| State | OH |
| Symbol | MEDP |
| Target High Price | 700.0 |
| Target Low Price | 370.0 |
| Target Mean Price | 595.9231 |
| Target Median Price | 615.0 |
| Total Cash | 502,688,000 |
| Total Cash Per Share | 18.01 |
| Total Debt | 144,112,000 |
| Total Revenue | 2,782,287,872 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 17.03 |
| Trailing P E | 35.812683 |
| Trailing Peg Ratio | 2.9349 |
| Triggerable | 1 |
| Two Hundred Day Average | 525.1973 |
| Two Hundred Day Average Change | 84.69269 |
| Two Hundred Day Average Change Percent | 0.1612588 |
| Type Disp | Equity |
| Volume | 155,250 |
| Website | https://www.medpace.com |
| Zip | 45,227 |